Monoclonal Antibody Therapy at DHCHD

Monoclonal Antibody Therapy at DHCHD

Currently, DHCHD is not able to get more monoclonal antibody treatments. We have requested an allocation from the state.

DHCHD will update the community when we receive another allocation and the plan to distribute treatments to those who medically qualify, and receive an order from their provider.

The FDA authorized the use of these monoclonal antibody therapies to treat mild-to-moderate COVID-19 in adults and pediatric patients when both of these apply:

The patient has a positive COVID-19 test result
The patient is at high risk for progressing to severe COVID-19, hospitalization, or both

https://www.hhs.gov/guidance/document/monoclonal-antibody-covid-19-infusion

Please contact your healthcare provider with questions.

(806) 244-4571

1411 Denver Ave.
Dalhart, TX 79022

Pay a Bill

Patient Portal

Price Transparency

Dallam Hartley Counties Hospital District is a special taxing unit subject to Texas Truth in Taxation requirements. Annual tax rate notices and related documents are posted here.

2025 NOTICE OF PUBLIC HEARING ON TAX INCREASE: Click Here

2025 PROPOSED TAX RATE BOARD APPROVAL: Click Here

A long-term care ombudsman helps residents of a nursing facility and residents of an assisted living facility resolve complaints. Help provided by an ombudsman is confidential and free of charge. To speak with an ombudsman, a person may call the toll-free number 1-800-252-2412.

Sec. 181.105. REQUIRED INFORMATION REGARDING CONSUMER ACCESS TO HEALTH RECORDS AND COMPLAINTS. (a) Except as provided by Subsection (b), a covered entity shall prominently post on the entity's Internet website and at any entity facility detailed instructions for a consumer to:
(1) request the consumer's health care records from the entity;
(2) contact the disciplinary or licensing authority for the covered entity; and
(3) file a consumer complaint as described by Section 181.103.
(b) This section does not apply to a covered entity that conducts claims processing, data processing, data analysis, utilization review, or billing on behalf of another covered entity that provides health care services directly to consumers.

Added by Acts 2025, 89th Leg., R.S., Ch. 650 (H.B. 4224), Sec. 1, eff. September 1, 2025.